Related references
Note: Only part of the references are listed.Unveiling Benznidazole's Mechanism of Action Through Overexpression of DNA Repair Proteins in Trypanosoma cruzi
Matheus Andrade Rajao et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2014)
New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice
Juan M. Bustamante et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Antiparasitic activities of novel ruthenium/lapachol complexes
Marilia I. F. Barbosa et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells
Eva Iniguez et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2013)
Chagas disease: control, elimination and eradication. Is it possible?
Jose Rodrigues Coura
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2013)
New ruthenium(II)/phosphines/diimines complexes: Promising antitumor (human breast cancer) and Mycobacterium tuberculosis fighting agents
Edjane R. dos Santos et al.
POLYHEDRON (2013)
Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
Belinda S. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi
Phercyles Veiga-Santos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains
Sabrina Cencig et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Searching for New Chemotherapies for Tropical Diseases: Ruthenium-Clotrimazole Complexes Display High in Vitro Activity against Leishmania major and Trypanosoma cruzi and Low Toxicity toward Normal Mammalian Cells
Alberto Martinez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
New Ruthenium(II)-Letrozole Complexes as Anticancer Therapeutics
Annie Castonguay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Biological activity of ruthenium nitrosyl complexes
Elia Tfouni et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2012)
Investigation on the pharmacological profile of antimony(III) complexes with hydroxyquinoline derivatives: anti-trypanosomal activity and cytotoxicity against human leukemia cell lines
Debora C. Reis et al.
BIOMETALS (2011)
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Alberta Bergamo et al.
DALTON TRANSACTIONS (2011)
Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis
Fernando R. Pavan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
A new nitrosyl ruthenium complex: Synthesis, chemical characterization, in vitro and in vivo antitumor activities and probable mechanism of action
Tassiele A. Heinrich et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: New achievements
Julio Benitez et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
Michael Groessl et al.
METALLOMICS (2011)
The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
Patricia S. Doyle et al.
PLOS PATHOGENS (2011)
Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
Julio A. Urbina
ACTA TROPICA (2010)
Tolerance of Benznidazole in Treatment of Chagas' Disease in Adults
Maria-Jesus Pinazo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity
Jean Jerley Nogueira Silva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Nitric oxide donor trans-[RuCl([15]aneN4)NO]2+as a possible therapeutic approach for Chagas' disease
Paulo M. M. Guedes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites
Alessio Bocedi et al.
FASEB JOURNAL (2010)
Risedronate metal complexes potentially active against Chagas disease
Bruno Demoro et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Nuclear Permeable Ruthenium(II)β-Carboline Complexes Induce Autophagy To Antagonize Mitochondrial-Mediated Apoptosis
Caiping Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Alvaro Jose Romanha et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2010)
Experimental Chemotherapy against Trypanosoma cruzi Infection Using Ruthenium Nitric Oxide Donors
Jean Jerley N. Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationships
Claudio Luis Donnici et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
A Cytotoxic Ruthenium Tris(Bipyridyl) Complex that Accumulates at Plasma Membranes
Olivier Zava et al.
CHEMBIOCHEM (2009)
Electron Microscopy in Antiparasitic Chemotherapy: A (Close) View to a Kill
M. A. Vannier-Santos et al.
CURRENT DRUG TARGETS (2009)
Approaches for the Development of New Anti-Trypanosoma cruzi Agents
Diogo Rodrigo Magalhaes Moreira et al.
CURRENT DRUG TARGETS (2009)
Potent in vitro anti-Trypanosoma cruzi activity of pyridine-2-thiol N-oxide metal complexes having an inhibitory effect on parasite-specific fumarate reductase
Marisol Vieites et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2008)
Natural Programmed Cell Death in T. cruzi Epimastigotes Maintained in Axenic Cultures
V. Jimenez et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy
Jean Jerley Nogueira Silva et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors
J. J. J. Silva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The future of Chagas disease control
Chris J. Schofield et al.
TRENDS IN PARASITOLOGY (2006)
Inactivation of parasite cysteine proteinases by the NO-donor 4-(phenylsulfonyl)-3-((2-(dimethylamino)ethyl)thio)-furoxan oxalate
P Ascenzi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
Toward a novel metal-based chemotherapy against tropical diseases.: 6.: Synthesis and characterization of new copper(II) and gold(I) clotrimazole and ketoconazole complexes and evaluation of their activity against Trypanosoma cruzi
M Navarro et al.
INORGANIC CHEMISTRY (2001)
Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi
G Venturini et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
